Effects of fixation and tissue processing on immunohistochemical demonstration of specific antigens

Biotechnic and Histochemistry

Volumn 71, Issue 5, 1996, Pages 224-230

  Arnold, M M ^a   Srivastava, Sudhir ^b   Fredenburgh, Jerry ^c   Stockard, Cecil R ^d   Myers, Russell B ^d   Grizzle, William E ^d  

^a Santa Rosa Memorial Hospital   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Richard Allan Scientific   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

antigen retrieval; biomarkers; fixation; immunohistochemistry

Indexed keywords

ANTIGEN; KERATIN; PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA;

ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; TISSUE FIXATION; TISSUE PREPARATION; TISSUE SECTION;

EID: 0029903998     PISSN: 10520295     EISSN: None     Source Type: Journal    
DOI: 10.3109/10520299609117164     Document Type: Article

References (14)

1. Boone, C. W. and Kelloff, G. J. 1994. Development of surrogate end point biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia. J. Cell. Biochem. (Suppl.) 19: 10-22.
2. Conry, R. M., LoBuglio. A. F., Kantor, J., Schlom, J., Leochel, F., Moore, S. E., Sumerel, L. A., Barlow, D. L., Abrams, S. and Cureil, D. T. 1994. Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res. 54: 1164-1168.
3. Deshane, J., Leochel, F., Conry, R. M., Siegal, G, P., King. C. R. and Curiel, D. T. 1994. Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 overexpressing cancer cell lines. Gene Therapy 1: 332-337.
4. Fox, C. H., Johnson, F. B., Whitting, J. and Roller, P. P. 1985. Formaldehyde fixation. J. Histochem. Cytochem. 33: 845-853.
5. Grizzle, W. E., Myers, R. B., Arnold, M. M. and Srivastava, S. 1994. Evaluation of biomarkers in breast and prostate cancer. J. Cell. Biochem. (Suppl.) 19: 259-266.
6. Grizzle, W. E., Myers, R. B. and Oelschlager, D. K. 1995. Prognostic biomarkers in breast cancer: factors affecting immunohistochemical evaluation. Breast 1: 243-250.
7. Kelloff, G. J., Boone, C. W., Crowell, J. A., Steele, V. E., Lubet, R. and Doody, L. A. 1994. Surrogate end point biomarkers for phase II cancer chemo-prevention trials. J. Cell. Biochem. (Suppl.) 19: 1-9.
8. Myers, R. B., Kudlow, J. E. and Grizzle, W. E. 1993. Expression of transforming growth factor alpha, epidermal growth factor and the epidermal growth factor receptor in benign prostatic hyperplasia and adenocarcinoma of the prostate. Modern Pathol. 6(6): 733-737.
9. erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. J. Natl. Cancer Inst. 86: 1140-1145.
10. Myers, R. B., Oelschlager, D., Srivastava, S. and Grizzle, W. E. 1994b. Accumulation of the p53 protein occurs more frequently in metastatic than in localized prostatic adenocarcinomas. The Prostate 25: 243-248.
11. Myers, R. B., Meredith, R. F., Schlom, J., LoBuglio, A. F., Bueschen, A. J., Wheeler, R. H., Stockard, C. R. and Grizzle, W. E. 1994c. Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomas. J. Urol. 152: 243-246.
12. Myers, R. B., Schlom, J., Srivastava, S. and Grizzle, W. E. 1995a. Expression of tumor associated glycoprotein-72 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Modern Pathol. 8: 260-265.
13. Myers, R. B., Srivastava, S. and Grizzle. W. E. 1995b. Lewis Y antigen as detected by the monoclonal antibody BR96 is expressed strongly in prostatic adenocarcinoma. J. Urol. 153: 1572-1574.
14. Shi, S., Key. M. E. and Kalra, K. L. 1991. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 39: 741-748.